IRIS Accounts Production v25.3.0.601 SC261160 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh SC261160 2024-03-31 SC261160 2025-03-31 SC261160 2024-04-01 2025-03-31 SC261160 2023-03-31 SC261160 2023-04-01 2024-03-31 SC261160 2024-03-31 SC261160 ns15:Scotland 2024-04-01 2025-03-31 SC261160 ns14:PoundSterling 2024-04-01 2025-03-31 SC261160 ns10:Director1 2024-04-01 2025-03-31 SC261160 ns10:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC261160 ns10:SmallEntities 2024-04-01 2025-03-31 SC261160 ns10:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 SC261160 ns10:SmallCompaniesRegimeForDirectorsReport 2024-04-01 2025-03-31 SC261160 ns10:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 SC261160 ns10:FullAccounts 2024-04-01 2025-03-31 SC261160 ns10:OrdinaryShareClass1 2024-04-01 2025-03-31 SC261160 ns10:Director2 2024-04-01 2025-03-31 SC261160 ns10:CompanySecretary1 2024-04-01 2025-03-31 SC261160 ns10:RegisteredOffice 2024-04-01 2025-03-31 SC261160 ns5:CurrentFinancialInstruments 2025-03-31 SC261160 ns5:CurrentFinancialInstruments 2024-03-31 SC261160 ns5:ShareCapital 2025-03-31 SC261160 ns5:ShareCapital 2024-03-31 SC261160 ns5:FurtherSpecificReserve3ComponentTotalEquity 2025-03-31 SC261160 ns5:FurtherSpecificReserve3ComponentTotalEquity 2024-03-31 SC261160 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 SC261160 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 SC261160 ns5:ShortLeaseholdAssets ns5:LandBuildings 2024-04-01 2025-03-31 SC261160 ns5:ComputerEquipment 2024-04-01 2025-03-31 SC261160 ns5:ShortLeaseholdAssets ns5:LandBuildings 2024-03-31 SC261160 ns5:ComputerEquipment 2024-03-31 SC261160 ns5:ShortLeaseholdAssets ns5:LandBuildings 2025-03-31 SC261160 ns5:ComputerEquipment 2025-03-31 SC261160 ns5:ShortLeaseholdAssets ns5:LandBuildings 2024-03-31 SC261160 ns5:ComputerEquipment 2024-03-31 SC261160 ns5:DeferredTaxation 2024-03-31 SC261160 ns5:DeferredTaxation 2025-03-31 SC261160 ns10:OrdinaryShareClass1 2025-03-31 SC261160 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 SC261160 ns5:FurtherSpecificReserve3ComponentTotalEquity 2024-03-31 SC261160 ns5:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31

REGISTERED NUMBER: SC261160 (Scotland)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

A & S Medical Services Ltd

| A & S Medical Services Ltd (Registered number: SC261160) |

Contents of the Financial Statements

for the Year Ended 31 March 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

| A & S Medical Services Ltd |

Company Information

for the Year Ended 31 March 2025

| DIRECTORS: | Dr Jagdeep Luthra

| Mrs Rekha Luthra

| SECRETARY: | Dr Jagdeep Luthra

| REGISTERED OFFICE: | c/o Dr Jagdeep Luthra

| 41 Craw Road

| Paisley

| Renfrewshire

| PA2 6AD

| REGISTERED NUMBER: | SC261160 (Scotland)

| ACCOUNTANTS: | Stevenson & Kyles

| Chartered Accountants

| 25 Sandyford Place

| Glasgow

| G3 7NG

| A & S Medical Services Ltd (Registered number: SC261160) |

Balance Sheet

31 March 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 225,967 |  | 226,289 |  |

CURRENT ASSETS

Cash at bank | 14,304 |  | 9,627 |  |

CREDITORS

Amounts falling due within one year | 5 | 151,473 |  | 142,506 |  |

NET CURRENT LIABILITIES | (137,169 | ) | (132,879 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | 88,798 |  | 93,410 |  |

PROVISIONS FOR LIABILITIES | 6 | 8,576 |  | 8,576 |  |

NET ASSETS | 80,222 |  | 84,834 |  |

CAPITAL AND RESERVES

Called up share capital | 7 | 2 |  | 2 |  |

Fair value reserve | 8 | 65,341 |  | 65,341 |  |

Retained earnings | 8 | 14,879 |  | 19,491 |  |

SHAREHOLDERS' FUNDS | 80,222 |  | 84,834 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

| A & S Medical Services Ltd (Registered number: SC261160) |

Balance Sheet - continued

31 March 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 October 2025 and were signed on its behalf by:

Dr Jagdeep Luthra - Director

| A & S Medical Services Ltd (Registered number: SC261160) |

Notes to the Financial Statements

for the Year Ended 31 March 2025

1. | STATUTORY INFORMATION

| A & S Medical Services Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Investment property | - | not provided

| Computer equipment | - | 25% on reducing balance

| Financial instruments

| Basic financial instruments, including debtors and creditors with no stated interest rate and receivable or payable within one year, are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 2 (2024 - 2 ) .

| A & S Medical Services Ltd (Registered number: SC261160) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2025

4. | TANGIBLE FIXED ASSETS

| Investment |  | Computer |

| property |  | equipment |  | Totals

£ | £ | £ |

| COST OR VALUATION

| At 1 April 2024

| and 31 March 2025 | 225,000 |  | 4,270 |  | 229,270 |  |

| DEPRECIATION

| At 1 April 2024 | - |  | 2,981 |  | 2,981 |  |

| Charge for year | - |  | 322 |  | 322 |  |

| At 31 March 2025 | - |  | 3,303 |  | 3,303 |  |

| NET BOOK VALUE

| At 31 March 2025 | 225,000 |  | 967 |  | 225,967 |  |

| At 31 March 2024 | 225,000 |  | 1,289 |  | 226,289 |  |

| Cost or valuation at 31 March 2025 is represented by:

| Investment |  | Computer |

| property |  | equipment |  | Totals

£ | £ | £ |

| Valuation in 2022 | 225,000 |  | - |  | 225,000 |  |

| Cost | - |  | 4,270 |  | 4,270 |  |

225,000 |  | 4,270 |  | 229,270 |  |

| The market values of the investment properties have been arrived at on the basis of a valuation carried out by the directors of the company who are not professionally qualified valuers. The

| valuation was arrived at by reference to market evidence of transaction prices for similar properties in their location and takes into account the state of the rental market in the areas where the properties are situated.

5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Taxation and social security | 2,747 |  | 2,351 |  |

| Other creditors | 148,726 |  | 140,155 |  |

151,473 |  | 142,506 |  |

6. | PROVISIONS FOR LIABILITIES

2025 | 2024 |

£ | £ |

| Deferred tax | 8,576 |  | 8,576 |  |

| A & S Medical Services Ltd (Registered number: SC261160) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2025

6. | PROVISIONS FOR LIABILITIES - continued

| Deferred |

| tax |

£ |

| Balance at 1 April 2024 | 8,576 |  |

| Balance at 31 March 2025 | 8,576 |  |

7. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2025 | 2024 |

| value: | £ | £ |

| 2 | Ordinary | £1 | 2 |  | 2 |  |

8. | RESERVES

| Fair |

| Retained |  | value |

| earnings |  | reserve |  | Totals

£ | £ | £ |

| At 1 April 2024 | 19,491 |  | 65,341 |  | 84,832 |  |

| Profit for the year | 11,388 |  | 11,388 |  |

| Dividends | (16,000 | ) | (16,000 | ) |

| At 31 March 2025 | 14,879 |  | 65,341 |  | 80,220 |  |

9. | RELATED PARTY DISCLOSURES

| One of the properties sub-let by the company is rented from Seema Luthra, the daughter of Mr and Mrs Luthra, on a full repairing and insuring lease at a nominal rental of £12 per annum.

10. | ULTIMATE CONTROLLING PARTY

| The company was under the control of the directors, Dr & Mrs Luthra, throughout the year. Dr and Mrs Luthra jointly own 100% of the company's issued share capital.